Lincoln Pharmaceuticals Ltd (LINCOLN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 294056, "name": "Lincoln Pharma.", "stock_name": "Lincoln Pharma.", "full_name": "Lincoln Pharmaceuticals Ltd", "name_url": "stocks-analysis/lincoln-pharma", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "618.20", "chg": 5.95, "chgp": "0.97%", "dir": 1, "prev_price": "612.25", "mcapval": "1,233.00 Cr", "mcap": "Micro Cap", "scripcode": 531633, "symbol": "LINCOLN", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE405C01035", "curr_date": "Aug 25, 03:30 PM", "curr_time": "20:34 PM", "last_traded_at": "Aug 25, 03:30 PM IST", "bse_nse_vol": "46.58 k", "exc_status": "Active", "traded_date": "Aug 25, 2026", "traded_date_str": "2026 08 25", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lincoln-pharma-294056-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Lincoln Pharmaceuticals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-is-rated-hold-4161237", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/LincolnPharmace_mojoScore_4161237.png", "date": "2026-08-19 10:10:03", "description": "Lincoln Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 27 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Are Lincoln Pharmaceuticals Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-lincoln-pharmaceuticals-ltd-latest-results-good-or-bad-4152300", "imagepath": "", "date": "2026-08-13 19:44:12", "description": "Lincoln Pharmaceuticals Ltd's latest financial results for Q4 FY26 reveal a complex picture characterized by strong revenue growth but stagnant profitability. The company reported net sales of ₹187.28 crores, reflecting an 11.36% increase year-on-year, driven by robust domestic demand and export performance. However, net profit showed only a marginal growth of 0.43% year-on-year, amounting to ₹11.63 crores, which raises concerns about operational efficiency as profitability did not keep pace with revenue expansion.\n\nThe operating margin for Q4 FY26 was recorded at 13.27%, a decline of 262 basis points compared to the previous year, indicating pressures from rising input costs and increased employee expenses. This margin compression highlights challenges in maintaining profitability amid a competitive landscape. The profit after tax margin also contracted to 6.21%, down from 6.89% in the previous year, furth..." }, { "title": "Lincoln Pharmaceuticals Ltd Reports Strong Quarterly Upswing Amid Positive Financial Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-reports-strong-quarterly-upswing-amid-positive-financial-trend-4152197", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/LincolnPharmace_fintrenddot_4152197.png", "date": "2026-08-13 15:00:11", "description": "Lincoln Pharmaceuticals Ltd has demonstrated a marked improvement in its financial performance for the quarter ended June 2026, signalling a positive shift in its financial trend after a period of stagnation. The company’s recent results reveal robust revenue growth, margin expansion, and key operational efficiencies that have contributed to an upgraded outlook from Sell to Hold by MarketsMOJO, reflecting renewed investor confidence in this micro-cap pharmaceutical player." }, { "title": "Lincoln Pharmaceuticals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-is-rated-hold-4142822", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/LincolnPharmace_mojoScore_4142822.png", "date": "2026-08-08 10:10:28", "description": "Lincoln Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 27 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "When is the next results date for Lincoln Pharmaceuticals Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-lincoln-pharmaceuticals-ltd-4142234", "imagepath": "", "date": "2026-08-07 23:18:27", "description": "The next results date for Lincoln Pharmaceuticals Ltd is scheduled for 13 August 2026...." }, { "title": "Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Signal Mild Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-technical-momentum-shifts-signal-mild-bullish-outlook-4134443", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/LincolnPharmace_technicaldot_4134443.png", "date": "2026-08-04 08:02:19", "description": "Lincoln Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by a complex interplay of technical indicators, including MACD, RSI, moving averages, and Bollinger Bands, which collectively paint a nuanced picture of the stock’s near-term prospects within the Pharmaceuticals & Biotechnology sector." }, { "title": "Lincoln Pharmaceuticals Ltd’s Subtle Shift: -0.48% Weekly Dip Amid Mixed Technical Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltds-subtle-shift--048-weekly-dip-amid-mixed-technical-signals-4132153", "imagepath": "", "date": "2026-08-02 10:00:07", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>27 Jul:</strong> MarketsMOJO upgrades Lincoln Pharmaceuticals Ltd to Hold on technical and valuation improvements</p>\n <p><strong>31 Jul:</strong> Technical momentum shifts to sideways trend amid mixed indicator signals</p>\n <p><strong>31 Jul:</strong> Week closes at Rs.579.10, down 0.48% despite Sensex gains</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.581.90</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.579.10</div><div class=\"stat-chang..." }, { "title": "Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4129431", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/LincolnPharmace_technicaldot_4129431.png", "date": "2026-07-31 08:00:37", "description": "Lincoln Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade in daily price performance, the stock’s monthly and weekly technical indicators present a complex picture, reflecting both bullish and bearish signals that investors should carefully analyse." }, { "title": "Lincoln Pharmaceuticals Ltd Upgraded to Hold on Technical and Valuation Improvements", "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-upgraded-to-hold-on-technical-and-valuation-improvements-4123554", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/LincolnPharmace_mojoScore_4123554.png", "date": "2026-07-28 08:11:27", "description": "Lincoln Pharmaceuticals Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators, valuation metrics, and financial trends despite some lingering challenges. The micro-cap pharmaceutical company’s recent performance and outlook have prompted analysts to revise their stance, signalling cautious optimism for investors." } ], "total": 1008, "sid": "294056", "stock_news_url": "https://www.marketsmojo.com/news/lincoln-pharmaceuticals-294056" }, "announcements": [ { "details": "Lincoln Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on December 07, 2019 for consider and approved draft scheme of amalgamation and withdrawal scheme approved by Board earlier", "source": "NSE", "caption": "Lincoln Pharmaceuticals Limited - Outcome of Board Meeting", "datetime": "09-Dec-2019" }, { "details": "Lincoln Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on November 14, 2019 for Considered and Approved Un-Audited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended on September 30, 2019", "source": "NSE", "caption": "Lincoln Pharmaceuticals Limited - Outcome of Board Meeting", "datetime": "14-Nov-2019" }, { "details": "Lincoln Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 22, 2019, titled \"press release dated October 22, 2019 titled \"Lincoln Pharmaceuticals Limited receives a Patent for Diclofenac Rectal Spray. \".", "source": "NSE", "caption": "Lincoln Pharmaceuticals Limited - Press Release", "datetime": "22-Oct-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Lincoln Pharmaceuticals Ltd has declared <strong>18%</strong> dividend, ex-date: 12 Sep 25", "dt": "2025-09-12", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Lincoln Pharmaceuticals Ltd has announced <strong>10:2</strong> stock split, ex-date: 19 Mar 09", "dt": "2009-03-19", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

27 Jul: MarketsMOJO upgrades Lincoln Pharmaceuticals Ltd to Hold on technical and valuation improvements

31 Jul: Technical momentum shifts to sideways trend amid mixed indicator signals

31 Jul: Week closes at Rs.579.10, down 0.48% despite Sensex gains

Read full news article

Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-07-31 08:00:37

Lincoln Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade in daily price performance, the stock’s monthly and weekly technical indicators present a complex picture, reflecting both bullish and bearish signals that investors should carefully analyse.

Read full news article

Lincoln Pharmaceuticals Ltd Upgraded to Hold on Technical and Valuation Improvements

2026-07-28 08:11:27

Lincoln Pharmaceuticals Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators, valuation metrics, and financial trends despite some lingering challenges. The micro-cap pharmaceutical company’s recent performance and outlook have prompted analysts to revise their stance, signalling cautious optimism for investors.

Read full news article